Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Neogenomics Inc (NEO)

Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,104,694
  • Shares Outstanding, K 127,712
  • Annual Sales, $ 591,640 K
  • Annual Income, $ -87,970 K
  • 60-Month Beta 1.19
  • Price/Sales 3.50
  • Price/Cash Flow 57.84
  • Price/Book 2.29
Trade NEO with:

Options Overview Details

View History
  • Implied Volatility 38.05% ( -10.48%)
  • Historical Volatility 43.42%
  • IV Percentile 2%
  • IV Rank 5.86%
  • IV High 105.85% on 10/25/23
  • IV Low 33.83% on 09/10/24
  • Put/Call Vol Ratio 0.02
  • Today's Volume 200
  • Volume Avg (30-Day) 122
  • Put/Call OI Ratio 0.31
  • Today's Open Interest 14,679
  • Open Int (30-Day) 13,959

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.05
  • Number of Estimates 5
  • High Estimate -0.04
  • Low Estimate -0.09
  • Prior Year -0.06
  • Growth Rate Est. (year over year) +16.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.05 +9.50%
on 09/10/24
16.97 -2.89%
on 08/23/24
-0.27 (-1.61%)
since 08/19/24
3-Month
12.93 +27.46%
on 06/26/24
18.28 -9.85%
on 07/31/24
+3.47 (+26.67%)
since 06/18/24
52-Week
11.03 +49.41%
on 10/04/23
21.22 -22.34%
on 12/22/23
+3.71 (+29.05%)
since 09/19/23

Most Recent Stories

More News
NeoGenomics: Q2 Earnings Snapshot

NeoGenomics: Q2 Earnings Snapshot

NEO : 16.48 (+1.98%)
NeoGenomics: Q1 Earnings Snapshot

NeoGenomics: Q1 Earnings Snapshot

NEO : 16.48 (+1.98%)
NeoGenomics: Q4 Earnings Snapshot

NeoGenomics: Q4 Earnings Snapshot

NEO : 16.48 (+1.98%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NYSE:BMY),(NYSE:TMO),(NASDAQ:NTRA),(NASDAQ:NEO) EQNX::TICKER_END

TDSGF : 0.1062 (-19.24%)
TELO.VN : 0.155 (unch)
BMY : 49.02 (-1.45%)
TMO : 620.25 (+1.66%)
NTRA : 127.13 (+0.02%)
NEO : 16.48 (+1.98%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

TDSGF : 0.1062 (-19.24%)
TELO.VN : 0.155 (unch)
BMY : 49.02 (-1.45%)
TMO : 620.25 (+1.66%)
NTRA : 127.13 (+0.02%)
NEO : 16.48 (+1.98%)
Altice USA, PENN Entertainment rise; Hess, NeoGenomics fall, Thursday, 12/28/2023

Stocks that traded heavily or had substantial price changes on Thursday: Altice USA, PENN Entertainment rise; Hess, NeoGenomics fall

ABX.TO : 27.44 (+0.29%)
BABA : 88.49 (+4.82%)
AMZN : 189.87 (+1.85%)
HES : 133.50 (+1.61%)
ATUS : 2.28 (-1.72%)
AAPL : 228.87 (+3.71%)
NEO : 16.48 (+1.98%)
NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response

FT. MYERS, FL / ACCESSWIRE / December 5, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, today announced new data highlighting its RaDaR® assay for minimal residual...

NEO : 16.48 (+1.98%)
NeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare Conference

FT. MYERS, FL / ACCESSWIRE / November 14, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, today announced the company will participate in the upcoming Piper Sandler...

NEO : 16.48 (+1.98%)
NeoGenomics: Q3 Earnings Snapshot

NeoGenomics: Q3 Earnings Snapshot

NEO : 16.48 (+1.98%)
NeoGenomics Reports Third Quarter 2023 Results

Third Quarter Revenue Increased 18% to $152 Million

NEO : 16.48 (+1.98%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology...

See More

Key Turning Points

3rd Resistance Point 17.18
2nd Resistance Point 16.97
1st Resistance Point 16.73
Last Price 16.48
1st Support Level 16.28
2nd Support Level 16.07
3rd Support Level 15.83

See More

52-Week High 21.22
Fibonacci 61.8% 17.33
Last Price 16.48
Fibonacci 50% 16.13
Fibonacci 38.2% 14.92
52-Week Low 11.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar